GDTC
CytoMed Therapeutics Limited
Price Chart
No historical data available
Latest Quote
$0.92
-0.03 (-3.16%)
Current Price
| Previous Close | $0.95 |
| Open | $0.86 |
| Day High | $0.92 |
| Day Low | $0.86 |
| Volume | 2,507 |
Stock Information
Note: Financial values converted from SGD to USD
| Shares Outstanding | 11.83M |
| Total Debt | $379K |
| Cash Equivalents | $1.64M |
| Revenue | $675K |
| Net Income | $-3.12M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $10.89M |
| EPS (TTM) | $-0.26 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About CytoMed Therapeutics Limited
CytoMed Therapeutics Limited, a clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. The company's lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord-derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore; and Business and Research Collaboration Agreement with SunAct Cancer Institute Private Limited to conduct clinical trials for the GMP grade CTM-GDT. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.
đ° Latest News
No news articles available at the moment. Check back later for updates on GDTC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $53,348 | $13,434 | $0 | $0 |
| Cost Of Revenue | $53,348 | $13,434 | $0 | $0 |
| Total Revenue | $254,521 | $54,532 | $0 | $0 |
| Operating Revenue | $254,521 | $54,532 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $16,403 | $15,938 | $40,237 | $98,215 |
| Total Expenses | $3,582,632 | $2,510,811 | $3,015,179 | $1,456,701 |
| Rent Expense Supplemental | $4,133 | $2,523 | $1,336 | $1,727 |
| Other Income Expense | $111,691 | $244,260 | $-411,226 | $-902,446 |
| Other Non Operating Income Expenses | $6,609 | - | $-77,485 | $-855,614 |
| Net Non Operating Interest Income Expense | $80,810 | $233,313 | $183,944 | $-96,570 |
| Interest Expense Non Operating | $16,403 | $15,938 | $40,237 | $98,215 |
| Operating Expense | $3,529,284 | $2,497,378 | $3,015,179 | $1,456,701 |
| Other Operating Expenses | $158,095 | $-96,597 | $673,442 | $-142,880 |
| Selling And Marketing Expense | $42,663 | $18,660 | $26,133 | $0 |
| General And Administrative Expense | $1,403,251 | $974,428 | $981,428 | $311,582 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,123,152 | $-1,974,655 | $-3,242,759 | $-2,456,814 |
| Net Interest Income | $80,810 | $233,313 | $183,944 | $-96,570 |
| Interest Income | $97,213 | $249,251 | $224,181 | $1,645 |
| Normalized Income | $-3,233,248 | $-2,208,115 | $-2,986,070 | $-2,439,789 |
| Net Income From Continuing And Discontinued Operation | $-3,123,152 | $-1,974,655 | $-3,242,759 | $-2,456,814 |
| Net Income Common Stockholders | $-3,123,152 | $-1,974,655 | $-3,242,759 | $-2,456,814 |
| Net Income | $-3,123,152 | $-1,974,655 | $-3,242,759 | $-2,456,814 |
| Net Income Including Noncontrolling Interests | $-3,135,611 | $-1,978,706 | $-3,242,974 | $-2,457,004 |
| Net Income Continuous Operations | $-3,135,611 | $-1,978,706 | $-3,242,974 | $-2,457,004 |
| Pretax Income | $-3,135,611 | $-1,978,706 | $-3,242,461 | $-2,455,717 |
| Special Income Charges | $224,188 | $0 | $0 | $220 |
| Earnings From Equity Interest | $-5,015 | $10,800 | $-24,479 | $-26,321 |
| Interest Income Non Operating | $97,213 | $249,251 | $224,181 | $1,645 |
| Operating Income | $-3,328,111 | $-2,456,279 | $-3,015,179 | $-1,456,701 |
| Depreciation Amortization Depletion Income Statement | $177,949 | $96,037 | $81,642 | $87,678 |
| Depreciation And Amortization In Income Statement | $177,949 | $96,037 | $81,642 | $87,678 |
| Amortization Of Intangibles Income Statement | $23,460 | $9,852 | $1,716 | $1,962 |
| Depreciation Income Statement | $154,489 | $86,184 | $79,926 | $85,717 |
| Gross Profit | $201,173 | $41,098 | $0 | $0 |
| Per Share | ||||
| Diluted EPS | - | - | $-0.31 | $-0.22 |
| Basic EPS | - | - | $-0.31 | $-0.22 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-52,575 | $-3,487 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,914,213 | $-1,933,095 | $-2,593,904 | $-2,028,739 |
| Total Unusual Items | $110,097 | $233,460 | $-309,263 | $-20,512 |
| Total Unusual Items Excluding Goodwill | $110,097 | $233,460 | $-309,263 | $-20,512 |
| Reconciled Depreciation | $315,091 | $263,133 | $299,057 | $308,252 |
| EBITDA (Bullshit earnings) | $-2,804,116 | $-1,699,635 | $-2,903,167 | $-2,049,251 |
| EBIT | $-3,119,207 | $-1,962,768 | $-3,202,224 | $-2,357,502 |
| Diluted NI Availto Com Stockholders | $-3,123,152 | $-1,974,655 | $-3,242,759 | $-2,456,814 |
| Minority Interests | $12,459 | $4,051 | $215 | $191 |
| Tax Provision | $0 | $0 | $512 | $1,287 |
| Gain On Sale Of Business | $230,864 | $0 | $0 | - |
| Impairment Of Capital Assets | $6,676 | $0 | $0 | - |
| Gain On Sale Of Security | $-114,092 | $233,460 | $-309,263 | $-20,731 |
| Other Taxes | $7,432 | $6,600 | $5,226 | $5,528 |
| Amortization | $23,460 | $9,852 | $1,716 | $1,962 |
| Research And Development | $1,739,894 | $1,498,249 | $1,247,307 | $1,194,794 |
| Selling General And Administration | $1,445,914 | $993,088 | $1,007,561 | $311,582 |
| Other Gand A | $366,937 | $411,926 | $401,873 | $144,569 |
| Insurance And Claims | $0 | $74,042 | $221,889 | $0 |
| Rent And Landing Fees | $4,133 | $2,523 | $1,336 | $1,727 |
| Salaries And Wages | $1,032,182 | $485,937 | $356,330 | $165,286 |
| Gain On Sale Of Ppe | - | $0 | $0 | $220 |
| Diluted Average Shares | - | - | $8,340,795 | $8,583,616 |
| Basic Average Shares | - | - | $8,340,795 | $8,583,616 |
Fetched: 2026-08-28
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,036,918 | $6,961,938 | $8,813,415 | $445,799 |
| Total Assets | $6,265,165 | $7,899,371 | $9,704,880 | $4,101,262 |
| Total Non Current Assets | $3,391,116 | $3,191,091 | $1,782,847 | $2,144,524 |
| Non Current Accounts Receivable | $382,332 | $392,311 | - | - |
| Investmentin Financial Assets | $14,288 | $0 | - | - |
| Goodwill And Other Intangible Assets | $97,995 | $73,009 | $9,740 | $14,758 |
| Other Intangible Assets | $97,716 | $72,730 | $9,461 | $14,479 |
| Current Assets | $2,874,049 | $4,708,280 | $7,922,033 | $1,956,737 |
| Prepaid Assets | $1,126,271 | $713,321 | $703,661 | $672,077 |
| Receivables | $103,612 | $95,102 | $160,650 | $45,180 |
| Other Receivables | $17,111 | $49,528 | $10,442 | $45,180 |
| Taxes Receivable | $4,116 | $2,269 | $3,696 | - |
| Accrued Interest Receivable | $895 | $28,569 | $146,512 | - |
| Accounts Receivable | $81,490 | $14,737 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $1,644,166 | $3,899,856 | $7,057,722 | $1,239,481 |
| Cash And Cash Equivalents | $1,644,166 | $3,899,856 | $7,057,722 | $1,239,481 |
| Cash Financial | $1,644,166 | $3,899,856 | $7,057,722 | $1,239,481 |
| Debt | ||||
| Total Debt | $378,628 | $363,476 | $351,528 | $3,310,523 |
| Long Term Debt And Capital Lease Obligation | $331,202 | $327,452 | $319,947 | $373,116 |
| Long Term Debt | $289,255 | $309,384 | $319,947 | $367,852 |
| Current Debt And Capital Lease Obligation | $47,426 | $36,024 | $31,581 | $2,937,408 |
| Current Debt | $32,049 | $29,541 | $26,619 | $2,931,358 |
| Other Current Borrowings | $32,049 | $29,541 | $26,619 | $2,931,358 |
| Net Debt | - | - | - | $2,059,729 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $887,631 | $803,421 | $882,475 | $3,641,240 |
| Total Non Current Liabilities Net Minority Interest | $331,202 | $327,452 | $319,947 | $373,116 |
| Current Liabilities | $556,429 | $475,969 | $562,529 | $3,268,124 |
| Other Current Liabilities | $19,666 | $9,372 | $115,036 | - |
| Current Deferred Liabilities | $143,434 | $85,641 | $6,591 | $7,143 |
| Payables And Accrued Expenses | $345,903 | $344,931 | $409,321 | $323,573 |
| Payables | $147,881 | $59,572 | $58,883 | $138,473 |
| Other Payable | $47,922 | $29,260 | $39,567 | $124,751 |
| Total Tax Payable | $2,083 | $0 | $0 | $1,252 |
| Accounts Payable | $97,875 | $30,312 | $19,316 | $11,477 |
| Equity | ||||
| Common Stock Equity | $5,134,912 | $7,034,947 | $8,823,155 | $460,557 |
| Total Equity Gross Minority Interest | $5,377,534 | $7,095,950 | $8,822,405 | $460,022 |
| Stockholders Equity | $5,134,912 | $7,034,947 | $8,823,155 | $460,557 |
| Other Equity Interest | $87,270 | - | $58,007 | - |
| Gains Losses Not Affecting Retained Earnings | $474,621 | $15,869 | $-170,578 | $-100,027 |
| Other Equity Adjustments | $413,206 | $58,048 | - | - |
| Retained Earnings | $-14,773,316 | $-11,650,164 | $-9,675,509 | $-6,432,751 |
| Long Term Equity Investment | $0 | $173,362 | $153,058 | $187,857 |
| Other | ||||
| Ordinary Shares Number | $9,280,843 | $9,054,531 | $9,046,157 | $8,583,616 |
| Share Issued | $9,280,843 | $9,054,531 | $9,046,157 | $8,583,616 |
| Tangible Book Value | $5,036,918 | $6,961,938 | $8,813,415 | $445,799 |
| Invested Capital | $5,456,217 | $7,373,872 | $9,169,720 | $3,759,767 |
| Working Capital | $2,317,619 | $4,232,311 | $7,359,504 | $-1,311,386 |
| Capital Lease Obligations | $57,324 | $24,551 | $4,962 | $11,313 |
| Total Capitalization | $5,424,168 | $7,344,331 | $9,143,101 | $828,409 |
| Minority Interest | $242,621 | $61,004 | $-750 | $-535 |
| Foreign Currency Translation Adjustments | $61,415 | $-42,179 | $-170,578 | $-100,027 |
| Capital Stock | $19,346,338 | $18,669,242 | $18,611,235 | $6,993,334 |
| Common Stock | $19,346,338 | $18,669,242 | $18,611,235 | $6,993,334 |
| Long Term Capital Lease Obligation | $41,947 | $18,068 | $0 | $5,264 |
| Current Deferred Revenue | $143,434 | $85,641 | $6,591 | $7,143 |
| Current Capital Lease Obligation | $15,377 | $6,483 | $4,962 | $6,049 |
| Current Accrued Expenses | $198,022 | $285,359 | $350,439 | $185,100 |
| Investments And Advances | $14,288 | $173,362 | $153,058 | $187,857 |
| Available For Sale Securities | $14,288 | - | - | - |
| Investmentsin Associatesat Cost | $0 | $173,362 | $153,058 | $187,857 |
| Goodwill | $279 | $279 | $279 | $279 |
| Net PPE | $2,896,502 | $2,552,410 | $1,620,049 | $1,941,909 |
| Accumulated Depreciation | $-1,731,940 | $-1,386,329 | $-1,070,768 | $-825,990 |
| Gross PPE | $4,628,442 | $3,938,738 | $2,690,818 | $2,767,899 |
| Other Properties | $2,134,923 | $1,561,892 | $1,307,630 | $1,335,167 |
| Machinery Furniture Equipment | $402,288 | $351,357 | $259,085 | $263,635 |
| Buildings And Improvements | $1,611,345 | $1,564,100 | $832,062 | $859,261 |
| Land And Improvements | $479,887 | $461,390 | $292,041 | $309,836 |
| Properties | $0 | $0 | $0 | $0 |
| Dueto Related Parties Current | - | - | $0 | $993 |
| Duefrom Related Parties Current | - | - | - | $0 |
Fetched: 2026-08-28
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,452,803 | $-3,298,835 | $-2,816,391 | $-1,468,971 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,901,109 | $-2,126,268 | $-2,770,652 | $-1,097,222 |
| Cash Flow From Continuing Operating Activities | $-2,901,109 | $-2,126,268 | $-2,770,652 | $-1,097,222 |
| Operating Gains Losses | $-170,201 | $-131,887 | $198,124 | $9,109 |
| Investing Activities | ||||
| Capital Expenditure | $-551,694 | $-1,172,566 | $-45,740 | $-371,750 |
| Investing Cash Flow | $729,135 | $883,908 | $-2,142,651 | $-371,365 |
| Cash Flow From Continuing Investing Activities | $729,135 | $883,908 | $-2,142,651 | $-371,365 |
| Net Other Investing Changes | $-16,104 | $-392,311 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $222,122 | $0 | $8,871,733 | $959,317 |
| Financing Cash Flow | $163,710 | $-50,916 | $8,567,975 | $760,075 |
| Cash Flow From Continuing Financing Activities | $163,710 | $-50,916 | $8,567,975 | $760,075 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $222,122 | $0 | $8,871,733 | $959,317 |
| Common Stock Issuance | $222,122 | $0 | $8,871,733 | $959,317 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-42,009 | $-34,978 | $-267,106 | $-336,413 |
| End Cash Position | $1,644,166 | $3,685,404 | $4,883,630 | $1,239,481 |
| Beginning Cash Position | $3,685,404 | $4,883,630 | $1,239,481 | $1,971,572 |
| Effect Of Exchange Rate Changes | $-32,974 | $95,049 | $-10,523 | $-23,579 |
| Changes In Cash | $-2,008,264 | $-1,293,276 | $3,654,672 | $-708,512 |
| Interest Paid Cff | $-16,403 | $-15,938 | $-36,652 | $-98,215 |
| Net Issuance Payments Of Debt | $-42,009 | $-34,978 | $-267,106 | $-101,027 |
| Net Long Term Debt Issuance | $-42,009 | $-34,978 | $-267,106 | $-101,027 |
| Long Term Debt Payments | $-42,009 | $-34,978 | $-267,106 | $-336,413 |
| Interest Received Cfi | $127,251 | $365,294 | $77,180 | $0 |
| Net Investment Purchase And Sale | $214,453 | $1,959,639 | $-2,174,092 | $0 |
| Sale Of Investment | $214,453 | $1,959,639 | - | - |
| Net Business Purchase And Sale | $955,229 | $123,852 | $0 | $0 |
| Sale Of Business | $955,229 | $123,852 | $0 | - |
| Net Intangibles Purchase And Sale | $-51,223 | $-73,920 | $0 | $0 |
| Purchase Of Intangibles | $-51,223 | $-73,920 | $0 | $0 |
| Net PPE Purchase And Sale | $-500,471 | $-1,098,646 | $-45,740 | $-371,365 |
| Purchase Of PPE | $-500,471 | $-1,098,646 | $-45,740 | $-371,750 |
| Taxes Refund Paid | $0 | $0 | $-1,721 | $0 |
| Interest Received Cfo | $0 | $1,900 | $489 | $1,645 |
| Change In Working Capital | $-380,938 | $-47,396 | $82,321 | $86,231 |
| Change In Other Working Capital | $56,533 | $80,256 | $1,532 | $-7,837 |
| Change In Payables And Accrued Expense | $-133 | $-65,595 | $84,916 | $207,971 |
| Change In Payable | $-133 | $-65,595 | $84,916 | $207,971 |
| Change In Receivables | $-437,338 | $-62,056 | $-4,126 | $-113,903 |
| Other Non Cash Items | $-80,810 | $-233,313 | $-183,944 | $96,570 |
| Stock Based Compensation | $544,684 | $0 | $0 | - |
| Unrealized Gain Loss On Investment Securities | $0 | $0 | $77,485 | $855,614 |
| Asset Impairment Charge | $6,676 | $0 | $0 | $1,075 |
| Depreciation Amortization Depletion | $315,091 | $263,133 | $299,057 | $308,252 |
| Depreciation And Amortization | $315,091 | $263,133 | $299,057 | $308,252 |
| Amortization Cash Flow | $23,964 | $10,356 | $5,018 | $10,357 |
| Amortization Of Intangibles | $23,964 | $10,356 | $5,018 | $10,357 |
| Depreciation | $291,127 | $252,777 | $294,038 | $297,895 |
| Earnings Losses From Equity Investments | $5,015 | $-10,800 | $24,479 | $26,321 |
| Gain Loss On Investment Securities | $10,293 | $-108,507 | $175,634 | - |
| Net Foreign Currency Exchange Gain Loss | $45,355 | $-12,580 | $-1,988 | $-16,993 |
| Gain Loss On Sale Of Business | $-230,864 | $0 | $0 | - |
| Net Income From Continuing Operations | $-3,135,611 | $-1,978,706 | $-3,242,461 | $-2,455,717 |
| Issuance Of Debt | - | $0 | $0 | $235,386 |
| Long Term Debt Issuance | - | $0 | $0 | $235,386 |
| Sale Of PPE | - | $0 | $0 | $384 |
| Gain Loss On Sale Of PPE | - | $0 | $0 | $-220 |
| Net Short Term Debt Issuance | - | - | $-235,386 | $-39,231 |
| Short Term Debt Payments | - | - | $-235,386 | $-274,617 |
| Short Term Debt Issuance | - | - | $0 | $235,386 |
| Purchase Of Investment | - | - | $-2,174,092 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
Fetched: 2026-08-28